Company
Somnics, Inc.
Headquarters: Zhubei, Taiwan
Market Cap
TW$200.8 Million
TWD as of Feb. 1, 2022
US$7.2 Million
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Somnics, Inc., a medical device company, focuses on developing technologies for the treatment of obstructive sleep apnea (OSA). The company offers iNAP One and iNAP Lite sleep therapy systems, which utilize oral negative pressure technology to treat OSA, a sleep-related breathing disorder. Somnics, Inc. was founded in 2011 and is based in Zhubei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Somnics, Inc. has the following listings and related stock indices.
Stock: TWSE: 6633 wb_incandescent